These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 375460)

  • 1. Levamisole and surgery in bronchial carcinoma patients: increase in deaths from cardiorespiratory failure.
    Anthony HM; Mearns AJ; Mason MK; Scott DG; Moghissi K; Deverall PB; Rozycki ZJ; Watson DA
    Thorax; 1979 Feb; 34(1):4-12. PubMed ID: 375460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levamisole and surgery in bronchial carcinoma patients: increase in deaths from cardiorespiratory failure.
    Amery WK
    Thorax; 1979 Feb; 34(1):141-2. PubMed ID: 441995
    [No Abstract]   [Full Text] [Related]  

  • 3. Final results of a multicenter placebo-controlled levamisole study of resectable lung cancer.
    Amery WK
    Cancer Treat Rep; 1978 Nov; 62(11):1677-83. PubMed ID: 365323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of levamisole on non-resected lung cancer--the results of randomized controlled study].
    Nishimura M; Morishita M; Urata A; Ota K
    Gan To Kagaku Ryoho; 1982 Nov; 9(11):1981-93. PubMed ID: 6307178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant levamisole in the treatment of patients with resectable lung cancer.
    Amery WK
    Ann Clin Res; 1980; 12 Suppl 27():1-83. PubMed ID: 6999969
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunopotentiation with levamisole in resectable bronchogenic carcinoma: a double-blind controlled trial; Study Group for Bronchogenic Carcinoma.
    Br Med J; 1975 Aug; 3(5981):461-4. PubMed ID: 1098727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant therapy with levamisole in resectable lung cancer.
    Amery WK; Cosemans J; Gooszen HC; Lopes Cardozo E; Louwagie A; Stam J; Swierenga J; Vanderschueren RG; Veldhuizen RW
    Recent Results Cancer Res; 1978; 68():268-77. PubMed ID: 379936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term survival following levamisole or placebo adjuvant treatment of colorectal cancer: a Western Cancer Study Group Trial.
    Chlebowski RT; Nystrom S; Reynolds R; Weiner JM; Bateman JR
    Oncology; 1988; 45(3):141-3. PubMed ID: 3285278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of inoperable non-small cell carcinoma of the lung with radiation therapy, with or without levamisole. A randomized trial of the Southeastern Cancer Study group.
    Krauss S; Comas F; Perez C; Gordon D; Philpott G; Broun G; Mill W; Robbins R; Smalley R; Mendiondo O
    Am J Clin Oncol; 1984 Oct; 7(5):405-12. PubMed ID: 6391141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant trial of levamisole in patients with squamous cancer of the head and neck: a preliminary report.
    Wanebo HJ; Hilal EY; Strong EW; Pinsky CM; Mike V; Oettgen HF
    Recent Results Cancer Res; 1978; 68():324-33. PubMed ID: 379937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind levamisole trial in resectable lung cancer.
    Amery WK
    Ann N Y Acad Sci; 1976; 277(00):260-8. PubMed ID: 793481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Adjuvant immunotherapy with levamisole in resected and then irradiated epidermoid bronchial cancer. Randomized study].
    Roeslin N; Lang JM; Wihlm JM; Morand G; Witz JP
    Presse Med; 1984 Jun; 13(23):1461-2. PubMed ID: 6233604
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effectiveness of immunomodulators in multimodal treatment of patients with lung cancer].
    Vagner VP; Voĭtkevich EG; Zakora GI; Chirvina ED
    Klin Med (Mosk); 1991 Dec; 69(12):55-9. PubMed ID: 1787682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interim analysis of a double-blind phase-III clinical trial of adjuvant levamisole versus control in resectable Dukes-C colon cancer: a study of the EORTC Gastrointestinal Tract Cancer Cooperative Group.
    Arnaud JP; Buyse M; Adloff M; Nordlinger B; Pector JC; Duez N
    Recent Results Cancer Res; 1988; 110():101-3. PubMed ID: 3043583
    [No Abstract]   [Full Text] [Related]  

  • 15. Prognosis of primarily treated localized laryngeal carcinoma ameliorated through levamisole treatment: a randomized pilot study.
    Mussche RA; Kluyskens P
    Oncology; 1980; 37(5):329-35. PubMed ID: 7003457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levamisole in squamous cell carcinoma of the head and neck.
    Olivari AJ; Glait HM; Guardo A; Califano L; Pradier R
    Cancer Treat Rep; 1979 Jun; 63(6):983-90. PubMed ID: 380804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levamisole versus placebo as an adjunct to primary therapy of laryngopharyngeal epidermoid carcinoma. Evaluation of the immune status.
    Mussche RA; Plum J; de Smedt M; Kluyskens P
    Acta Otorhinolaryngol Belg; 1977; 31(6):566-77. PubMed ID: 339662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levamisole or placebo after effective chemotherapy for remission and survival prolongation in advanced human solid tumors--a double-blind randomized trial.
    Focan C; Schyns-Mosen J; Focan-Henrard D
    Acta Oncol; 1989; 28(1):105-6. PubMed ID: 2650718
    [No Abstract]   [Full Text] [Related]  

  • 19. Levamisole treatment in ulcus cruris. A double-blind placebo-controlled study.
    Morias J; Peremans W; Campaert H; Mertens RL
    Arzneimittelforschung; 1979; 29(7):1050-2. PubMed ID: 387047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy versus chemoimmunotherapy with levamisole or Corynebacterium parvum in advanced lung cancer.
    Chahinian AP; Goldberg J; Holland JF; Reisman A; Jaffrey IS; Mandel EM
    Cancer Treat Rep; 1982 Jun; 66(6):1291-7. PubMed ID: 6282455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.